A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT01397578 · COMPLETED
Trial details
- NCT number
- NCT01397578
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-31
- Primary completion
- 2014-04-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.